首页>新闻资讯 2025-07-03 11:11:19
「同位素标记抑制剂」CAS:2070015-14-2|Atovaquone-d4
生物活性:Atovaquone-d4 is the deuterium labeled Atovaquone. Atovaquone is a medication used to treat or prevent for pneumocystis pneumonia, toxoplasmosis, malaria, and babesia[1].
IC50 & Target:Plasmodium
分子量:370.86
Formula:C22H15D4ClO3
CAS 号:2070015-14-2
非标记 CAS:95233-18-4
性状:固体
颜色:Light yellow to yellow
中文名称:阿托伐醌 d4
运输条件:Room temperature in continental US; may vary elsewhere.
储存方式:Powder:-20°C:3 years,4°C:2 years
In solvent:-80°C:6 months,-20°C:1 month
纯度 & 产品资料
纯度: 99.8%
参考文献
[1]. Looareesuwan, S., et al., Clinical studies of atovaquone, alone or in combination with other antimalarial drugs, for treatment of acute uncomplicated malaria in Thailand. Am J Trop Med Hyg, 1996. 54(1): p. 62-6.
[Content Brief]
推荐新闻
-
发布时间 | 2026-04-29 11:39:17
anti-tylosin 兔抗泰乐菌素多克隆抗体
-
发布时间 | 2026-04-29 11:38:59
anti-chlorinated phenols 兔抗氯代酚多克隆抗体
-
发布时间 | 2026-04-29 11:38:39
anti-D1-Nt (PsbA) 兔抗光系统II D2蛋白(PsbD,N段)多克隆抗体
-
发布时间 | 2026-04-29 11:38:14
anti-Hepatits B surface (HBsAg) 小鼠抗乙肝表面抗体 (HBsAg)单克隆抗体
-
发布时间 | 2026-04-29 11:37:56
孔雀石绿-甲基-D12,Malachite Green-methyl-D12,569-64-2